Hydroquinidine Versus Placebo in Patients With Brugada Syndrome

NCT00927732 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

64

Enrollment

OTHER

Sponsor class

Stopped insufficient recruitment, a lot of premature study discontinuations

Conditions

Brugada Syndrome

Interventions

DRUG: hydroquinidine
DRUG: placebo (sugar)

Sponsor

Nantes University Hospital

Collaborators

[object Object]